• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

acute myeloid leukemia (AML) - Articles and news items

Immune receives FDA guidance for acute myeloid leukaemia Phase III trial

Industry news / 28 October 2016 / Niamh Louise Marriott, Digital Content Producer

The proposed phase III study design reviewed by the FDA guidance focuses on overall survival as the primary endpoint, including Leukaemia Free Survival…

Daiichi Sankyo enrols first patient in Phase III acute myeloid leukaemia trial

Industry news / 17 October 2016 / Niamh Louise Marriott, Digital Content Producer

Daiichi Sankyo has enrolled their first patient in the global phase 3 QuANTUM-First study evaluating the oral FLT3-ITD inhibitor quizartinib in patients…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +